Abstract
Leukoplakia and erythroplakia are the two most common potentially malignant disorders of the oral cavity. Both lesions in a small and significant proportion of cases, respectively, turn into cancer. Most lesions are asymptomatic, and the main objective of treatment is to prevent their malignant transformation. The role of the dentist in the diagnosis and management cannot be underestimated, and this chapter provides an overview of the current concepts and practical diagnosis and treatment guidelines based on our clinical experience.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Sources
Amagasa T, Yamashiro M, Uzawa N. Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol. 2011;16:5–14.
A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia. Front Oral Health. 2023;4. https://doi.org/10.3389/froh.2023.1088022.
Awadallah M, Idle M, Patel K, Kademani D. Management update of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):628–36.
Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Nair R, Sasser H, Schifter M, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007a;103(Suppl):S19.e1–12. https://doi.org/10.1016/j.tripleo.2006.10.015. Epub 2007 Jan 25
Brennan M, Migliorati CA, Lockhart PB, Wray D, Al-Hashimi I, Axéll T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Nair R, Sasser H, Schifter M, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I. Management of oral epithelial dysplasia: a review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007b;103(Suppl):S19.e1–12. https://doi.org/10.1016/j.tripleo.2006.10.015. Epub 2007 Jan 25
Celentano A, Glurich I, Borgnakke WS, Farah CS. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia and proliferative verrucous leukoplakia-A systematic review of retrospective studies. Oral Dis. 2021;27(4):848–80. https://doi.org/10.1111/odi.13363. Epub 2020 May 12
Cerqueira JM, Pontes FS, Santos-Silva AR, Almeida OP, Costa RF, Fonseca FP, Gomez RS, Neto NC, Miyahara LA, Rodrigues-Fernandes CI, Neto ED, Araújo AL. Malignant transformation of oral leukoplakia: a multicentric retrospective study in Brazilian population. Med Oral Patol Oral Cir Bucal. 2021;26(3):e292–8. https://doi.org/10.4317/medoral.24175. PMID: 33247570; PMCID: PMC8141311
Chuang SL, Wang CP, Chen MK, Su WW, Su CW, Chen SL, Chiu SY, Fann JC, Yen AM. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: a prospective cohort study of Taiwanese nationwide oral cancer screening program. Oral Oncol. 2018;87:58–63.
de Pauli PM, Migliorati CA, Schausltz Pereira Faustino I, Linhares Almeida Mariz BA, Oliveira Corrêa Roza AL, Agustin Vargas P, Franco Paes Leme A, Bianca Brandão T, Prado Ribeiro AC, Ajudarte Lopes M, Santos-Silva AR. Laser excision of oral leukoplakia: does it affect recurrence and malignant transformation? A systematic review and meta-analysis. Oral Oncol. 2020;109:104850. https://doi.org/10.1016/j.oraloncology.2020.104850. Epub ahead of print
Goodson ML, Sloan P, Robinson CM, Cocks K, Thomson PJ. Oral precursor lesions and malignant transformation–who, where what, and when? Br J Oral Maxillofac Surg. 2015;53(9):831–5.
Gouvêa AF, Moreira AE, Reis RR, de Almeida OP, Lopes MA. Proliferative verrucous leukoplakia, squamous cell carcinoma and axillary metastasis. Med Oral Patol Oral Cir Bucal. 2010;15(5):e704–8.
Holmstrup P. Oral erythroplakia-what is it? Oral Dis. 2018;24(1–2):138–43.
IARC Perspective on Oral Cancer Prevention. N Engl J Med. 2022;387(21):1999–2005. https://doi.org/10.1056/NEJMsr2210097.
Jeong WJ, Paik JH, Cho SW, Sung MW, Kim KH, Ahn SH. Excisional biopsy for management of lateral tongue leukoplakia. J Oral Pathol Med. 2012;41(5):384–8.
Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D'Souza G, Gurenlian J, Kalmar JR, Kerr AR, Lambert PM, Patton LL, Sollecito TP, Truelove E, Tampi MP, Urquhart O, Banfield L, Carrasco-Labra A. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American dental association. J Am Dent Assoc. 2017;148(10):712–727.e10. https://doi.org/10.1016/j.adaj.2017.07.032.
Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. 2008. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev (4): CD001829.
Lopes MA. Proliferative verrucous leukoplakia may initially mimic lichenoid reactions. World J Clin Cases. 2015;3(10):861–5.
Malignant transformation of oral leukoplakia: a multicentric retrospective study in Brazilian population. Med Oral Patol Oral y Cir Bucal. 2021:e292–e298. https://doi.org/10.4317/medoral.24175.
Muller S, Tilakaratne WM. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue. Head Neck Pathol. 2022;16(1):54–62. https://doi.org/10.1007/s12105-021-01402-9. Epub 2022 Mar 21. PMID: 35312982; PMCID: PMC9018914
Oral leukoplakia in adolescents: Report of a rare case and review of the literature. Oral Oncol. 2021;122:105565. https://doi.org/10.1016/j.oraloncology.2021.105565.
Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia. Oral Oncol. 2021;116:105144. https://doi.org/10.1016/j.oraloncology.2020.105144.
Paglioni MP, Khurram SA, Ruiz BII, Lauby-Secretan B, Normando AG, Ribeiro ACP, Brandão TB, Palmier NR, Lopes MA, da Silva Guerra EN, Meleti M, Migliorati CA, Carvalho AL, de Matos LL, Kowalski LP, Santos-Silva AR. Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022;S2212-4403(22):01054–9. https://doi.org/10.1016/j.oooo.2022.07.006. Epub ahead of print
Pindborg JJ, Reichart PA, Smith CJ. World Health Organization: histological typing of cancer and precancer of the oral mucosa. 2nd ed. Berlin: Springer; 1997.
Robledo-Sierra J, Ben-Amy DP, Varoni E, Bavarian R, Simonsen JL, Paster BJ, Wade WG, Kerr R, Peterson DE, Frandsen LE. World Workshop on Oral Medicine VII: Targeting the oral microbiome Part 2: Current knowledge on malignant and potentially malignant oral disorders. Oral Dis. 2019;25(Suppl 1):28–48. https://doi.org/10.1111/odi.13107.
Rodrigues-Fernandes CI, Arboleda LPA, Vargas PA, Lopes MA, Santos-Silva AR. Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia. Oral Oncol. 2021;116:105144. https://doi.org/10.1016/j.oraloncology.2020.105144. Epub 2021 Jan 13
Speight PM. An overview of the classification and predictive value of oral epithelial dysplasia. IAOP; 2010.
Sperandio M, Warnakulasuriya S, Soares AB, Passador-Santos F, Mariano FV, Lima CSP, Scarini JF, Dominguete MHL, de Camargo MP, Montalli VAM, Hellmeister L, de Araújo VC. Oral epithelial dysplasia grading: Comparing the binary system to the traditional 3-tier system, an actuarial study with malignant transformation as outcome. J Oral Pathol Med. 2022; https://doi.org/10.1111/jop.13365. Epub ahead of print
Stojanov IJ, Woo SB. AAOM clinical practice statement subject: leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126(4):331–4.
van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23.
Villa A, Celentano A, Glurich I, Borgnakke WS, Jensen SB, Peterson DE, Delli K, Ojeda D, Vissink A, Farah CS. World Workshop on Oral Medicine VII: Prognostic biomarkers in oral leukoplakia: A systematic review of longitudinal studies. Oral Dis. 2019;25 Suppl 1(Suppl 1):64–78. https://doi.org/10.1111/odi.13087. PMID: 31140698; PMCID: PMC6544170
Villa A, Menon RS, Kerr AR, de Abreu AF, Guollo A, Ojeda D, Woo SB. Proliferative leukoplakia: proposed new clinical diagnostic criteria. Oral Dis. 2018;24(5):749–60.
Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):582–90.
Wei L, Wang Y-F, Zhou H-W, Shi P, Zhou Z-T, Tan G-Y. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer. 2010;10:685.
World Health Organization. Pathology and genetics of head and neck tumors: classification of tumors. Lyon: IARC Press; 2005. p. 283–327.
Acknowledgments
The São Paulo State Research Foundation (FAPESP, São Paulo, Brazil, grant number JFS 19/09419-0) and the Coordination of Training of Higher Education Graduate Foundation (CAPES, Brasilia, Brazil, finance code 001).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Santos-Silva, A.R. et al. (2023). Oral Leukoplakia and Erythroplakia. In: Santos-Silva, A.R., Lopes, M.A., Scarini, J.F., Vargas, P.A., Almeida, O.P.d. (eds) Clinical Decision-Making in Oral Medicine. Springer, Cham. https://doi.org/10.1007/978-3-031-14945-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-031-14945-0_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14944-3
Online ISBN: 978-3-031-14945-0
eBook Packages: MedicineMedicine (R0)